IDSA members Archana Chatterjee, MD, FIDSA of Rosalind Franklin University and Myron Cohen, MD, FIDSA of UNC Chapel Hill share insight on COVID-19 vaccines and prevention in immunocompromised individuals, including current recommendations and the role of antibody testing.

IDSA COVID-19 Guidelines co-authors Rajesh Gandhi, MD, FIDSA and Adarsh Bhimraj, MD, FIDSA provide the latest information on COVID-19 treatments, including the potential role of combination therapies, newer therapies such as nirmatrelvir and strovimab, and their thoughts on President Biden's "Test to Treat" initiative.